Dr. Agarwals Health Care: Q2 FY27 revenue up 31.4%, profit after tax up 55.8%
Q2 FY27 revenue up 31.4% to Rs. 655 crore, profit after tax up 55.8% to Rs. 57 crore, EBITDA margin easing to 27.9%.
By ScoutQuest · · 1 min read
- Q2 FY27 Revenue
- Revenue from operations rose 31.4% year on year to Rs. 655 crore from Rs. 499 crore
- Q2 FY27 PAT
- Profit after tax rose 55.8% to Rs. 57 crore
- Q2 FY27 EBITDA Margin
- EBITDA margin slipped to 27.9% from 28.4% a year earlier
- Period
- Q2 & H1 FY27 ended September 30, 2026
- Positioning
- The presentation describes a 324-facility eye care network at H1 FY27, 94.1% of it in India across South, West, North and East plus 19 international facilities, served by 1,111 doctors.
📈 Q2 FY27 consolidated revenue from operations rose 31.4% year on year to Rs. 655 crore from Rs. 499 crore, EBITDA - IndAS grew 28.8% to Rs. 186 crore and profit after tax rose 55.8% to Rs. 57 crore; the EBITDA margin slipped to 27.9% from 28.4% a year earlier.
📈 For H1 FY27 revenue was Rs. 1,269 crore, up 28.7% from Rs. 986 crore, and profit after tax Rs. 112 crore against Rs. 75 crore, up 50.1%, with the EBITDA margin at 28.2% versus 28.3%. The full-year figures printed alongside are FY26 revenue of Rs. 2,080 crore and profit after tax of Rs. 168 crore.
🏭 The deck shows 324 facilities at the end of H1 FY27, 305 of them in India (94.1%) including 200 in South India, and 19 international; 1,86,923 surgeries were performed in the half year with 18,43,809 patients served and 1,111 doctors.
🏭 For FY27E management states a total contribution of 65 facilities, 55 of them surgical, split South 25, West 15, North 20 and East 5, and says it plans to add a facility in Zambia and enter Ethiopia; it also lists 243 facilities set up since FY22 and a 94.9% organic share of additions in H1 FY27.
Also from Dr. Agarwals Health Care
Monitoring agency report for the September 30, 2026 quarter: no material deviation in IPO proceeds use
5 Nov 2026
Consolidated results for the 30-Sep-26
5 Nov 2026
Board approves Q2 and H1 FY27 results; Dr. Amar Agarwal re-designated Executive Chairman (Whole-Time Director)
5 Nov 2026
More numbers
- Revenue from operations, Q2 FY27655 (₹ Cr.)
- Profit after tax, Q2 FY2757 (₹ Cr.)
- Revenue from operations YoY growth, Q2 FY2731.4%
- EBITDA - IndAS margin, Q2 FY2727.9%
- Revenue from operations, H1 FY271,269 (₹ Cr.)
- Profit after tax, H1 FY27112 (₹ Cr.)
- Revenue from operations, FY262,080 (₹ Cr.)
- Total number of facilities, H1 FY27324
- Number of doctors, H1 FY271,111
- Total number of surgeries performed, H1 FY271,86,923
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.